We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Advises Drugmakers to Include Geriatric Patients in Clinical Trials
ICH Advises Drugmakers to Include Geriatric Patients in Clinical Trials
November 16, 2009
Sponsors should include at least 100 geriatric patients in clinical trials of new drugs to detect clinically important differences between patient populations,
according to an International Conference on Harmonisation (ICH) question-and-answer (Q&A) document.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor